TGS


MHRA approves Linerixibat (Lynavoy) for the treatment of itch due to biliary tract disease

MHRA approves Linerixibat (Lynavoy) for the treatment of itch due to biliary tract disease

https://www.gov.uk/government/news/mhra-approves-linerixibat-lynavoy-for-the-treatment-of-itch-due-to-biliary-tract-disease

seen at 15:14, 1 May in News and communications.